fluphenazine vs thioridazine
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of fluphenazine and thioridazine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Prolixin
Mellaril
Fluphenazine (Prolixin) is a medicine used to treat psychotic disorders. It helps manage symptoms like hallucinations and confused thinking.
Thioridazine is a medicine used to treat schizophrenia. It is only used when other antipsychotic medicines have not worked well enough.
Fluphenazine is used to manage the symptoms of psychotic disorders. These disorders can cause problems with thinking, feeling, and behavior. This medicine can help reduce hallucinations and other symptoms of psychosis.
Thioridazine is used to manage schizophrenia in adults and children. You should only use this medicine if other antipsychotic medicines have not worked for you. This is because thioridazine can cause serious heart problems.
Fluphenazine belongs to a class of drugs called typical antipsychotics. It works by changing the way certain chemicals in your brain work. This helps to reduce psychotic symptoms.
Thioridazine affects the balance of certain chemicals in the brain. These chemicals, like dopamine, can affect mood and behavior. By changing the balance, thioridazine helps to reduce symptoms of schizophrenia.
- • Extrapyramidal symptoms (muscle stiffness, tremors, slow movement)
- • Drowsiness
- • Restlessness
- • Drowsiness
- • Dry mouth
- • Blurred vision
- • Constipation
- • Nausea
- Sedation 19
- Anxiety 13
- Suicide Attempt 12
- Schizophrenia 11
- Blood Pressure Decreased 10
- Weight Increased 8
- Dyspnoea 7
- Dystonia 6
- Hyperglycaemia 6
- Hypoxia 6
Fluphenazine may increase the risk of death in elderly patients with dementia-related psychosis. Fluphenazine is not approved for treating dementia-related psychosis. Tell your doctor right away if you have Neuroleptic Malignant Syndrome (NMS) symptoms like high fever, stiff muscles, confusion, sweating, fast or irregular heartbeat.
Thioridazine can cause a life-threatening heart rhythm problem called Torsades de pointes, which can lead to sudden death. Because of this risk, only use thioridazine if other antipsychotic medicines have not worked. Elderly patients with dementia-related psychosis who are treated with antipsychotic drugs have an increased risk of death.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if fluphenazine will harm your unborn baby. Talk to your doctor about the risks and benefits of taking fluphenazine during pregnancy.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if thioridazine will harm your unborn baby. Talk to your doctor about the risks and benefits of taking thioridazine during pregnancy and breastfeeding.
Also Compare, Nearby Drugs
Compare fluphenazine with
Compare thioridazine with
How to Read This fluphenazine vs thioridazine Comparison
fluphenazine is classified in the Typical Antipsychotic (Phenothiazine) drug class, while thioridazine sits within the Typical Antipsychotic (Phenothiazine) class. Because both drugs share the same classification, they are often considered interchangeable in theory, but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, fluphenazine has 65 submissions while thioridazine has 33. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for fluphenazine or thioridazine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.